PST2 COST-EFFECTIVENESS OF LOSARTAN IN PATIENTS WITH HYPERTENSION AND LVH- AN ECONOMIC EVALUATION FOR THE NETHERLANDS BASED ON THE LIFE-STUDY
Nov 1, 2005, 00:00 AM
10.1016/S1098-3015(10)67611-5
https://www.valueinhealthjournal.com/article/S1098-3015(10)67611-5/fulltext
Section Title :
Section Order :
191
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)67611-5&doi=10.1016/S1098-3015(10)67611-5